tosufloxacin has been researched along with Mycoplasma dispar Infection in 3 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawai, Y | 1 |
| Miyashita, N | 1 |
| Kubo, M | 1 |
| Akaike, H | 1 |
| Kato, A | 1 |
| Nishizawa, Y | 1 |
| Saito, A | 1 |
| Kondo, E | 1 |
| Teranishi, H | 1 |
| Ogita, S | 1 |
| Tanaka, T | 1 |
| Kawasaki, K | 1 |
| Nakano, T | 1 |
| Terada, K | 1 |
| Ouchi, K | 1 |
| Ishiguro, N | 1 |
| Koseki, N | 1 |
| Kaiho, M | 1 |
| Ariga, T | 1 |
| Kikuta, H | 1 |
| Togashi, T | 1 |
| Oba, K | 1 |
| Morita, K | 1 |
| Nagano, N | 1 |
| Nakanishi, M | 1 |
| Hara, K | 1 |
| Hazama, K | 1 |
| Watanabe, T | 1 |
| Yamanaka, T | 1 |
| Sasaki, S | 1 |
| Furuyama, H | 1 |
| Shibata, M | 1 |
| Shida, S | 1 |
| Ishizaka, A | 1 |
| Tabata, Y | 1 |
| Aoyagi, H | 1 |
| Naito, H | 1 |
| Yoshioka, M | 1 |
| Horino, A | 1 |
| Kenri, T | 1 |
| Sakata, H | 1 |
1 trial available for tosufloxacin and Mycoplasma dispar Infection
| Article | Year |
|---|---|
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Drug Resis | 2013 |
2 other studies available for tosufloxacin and Mycoplasma dispar Infection
| Article | Year |
|---|---|
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Drug Resistance, Bacterial; | 2017 |
[Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae].
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Fluoroquinolones; Humans; Infant; Naphth | 2012 |